Dixon Anne E, Johnson Scott E, Griffes Laurianne V, Raymond Danielle M, Ramdeo Ramona, Soloveichik Avigail, Suratt Benjamin T, Cohen Rubin I
Department of Medicine, University of Vermont College of Medicine, Burlington, VT, USA .
J Asthma. 2011 Oct;48(8):811-7. doi: 10.3109/02770903.2011.613507.
Obesity is a risk factor for asthma. Studies in mice suggest that the adipokines leptin and adiponectin affect asthmatic responses. The purpose of this study was to determine if adipokines associated with obesity are (1) altered in obese women with asthma compared to controls and (2) associated with increased cytokines and chemokines involved in allergic inflammation.
We performed a cross-sectional study of asthmatic and non-asthmatic obese premenopausal women. Participants answered questionnaires and performed lung function tests. Serum and peripheral blood mononuclear cells (PBMCs) were collected for analysis of cytokines and adipokines.
A total of 22 asthmatic (mean body mass index 40.0 ± 5.1 kg/m(2)) and 20 non-asthmatic women (mean body mass index 41.3 ± 5.6 kg/m(2)) participated. We found no difference in serum adipokine concentrations between asthmatics and non-asthmatics. Serum adiponectin correlated positively with PBMC eotaxin (r(s) = 0.55, p = .0003) and RANTES (regulated upon activation, normal T-cell expressed, and secreted) (r(s) = 0.36, p = .03), whereas serum leptin correlated negatively with PBMC eotaxin (r(s) = -0.34, p = .04). There was a negative correlation between serum adiponectin and PBMC interferon-γ (r(s) = -0.41, p = .01).
Perturbations of adipokines that occur in obesity were correlated with decreased cytokine production typically associated with allergic responses in PBMC of obese premenopausal women. This study suggests that although obese asthmatics may have elements of Th2-mediated inflammation, adipokine derangements in obesity are associated with Th1 rather than Th2 bias. Obesity has complex effects on allergic inflammation and is likely to be important modifier of the pathogenesis of airway disease in asthma.
肥胖是哮喘的一个危险因素。对小鼠的研究表明,脂肪因子瘦素和脂联素会影响哮喘反应。本研究的目的是确定与肥胖相关的脂肪因子是否:(1)与对照组相比,在患有哮喘的肥胖女性中发生改变;(2)与参与过敏性炎症的细胞因子和趋化因子增加有关。
我们对患有哮喘和未患哮喘的肥胖绝经前女性进行了一项横断面研究。参与者回答问卷并进行肺功能测试。收集血清和外周血单核细胞(PBMC)用于分析细胞因子和脂肪因子。
共有22名哮喘患者(平均体重指数40.0±5.1kg/m²)和20名非哮喘女性(平均体重指数41.3±5.6kg/m²)参与。我们发现哮喘患者和非哮喘患者的血清脂肪因子浓度没有差异。血清脂联素与PBMC嗜酸性粒细胞趋化蛋白(r(s)=0.55,p=0.0003)和调节激活正常T细胞表达和分泌因子(RANTES)(r(s)=0.36,p=0.03)呈正相关,而血清瘦素与PBMC嗜酸性粒细胞趋化蛋白呈负相关(r(s)= -0.34,p=0.04)。血清脂联素与PBMC干扰素-γ之间存在负相关(r(s)= -0.41,p=0.01)。
肥胖时发生的脂肪因子紊乱与肥胖绝经前女性PBMC中通常与过敏反应相关的细胞因子产生减少有关。这项研究表明,尽管肥胖哮喘患者可能存在Th2介导的炎症成分,但肥胖时的脂肪因子紊乱与Th1而非Th2偏向有关。肥胖对过敏性炎症有复杂影响,可能是哮喘气道疾病发病机制的重要调节因素。